Dalfampridine

Ended Awarded

Contract number
VA77017J0923
Awardee
Awarding agency
Obligated
$485,835

Award facts

Contract value 100% obligated
$485,835.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Veterans Integrated Service Network 12 Veterans Health Administration, Department of Veterans Affairs
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Ardsley, NY 10502, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Veterans Affairs (VA) Veterans Health Administration and Veterans Integrated Service Network 12 awarded a firm fixed price delivery order to Acorda Therapeutics, Inc. for the drug Dalfampridine. The $485,835.00 contract is being fulfilled through the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which Acorda holds. Acorda is a biotechnology company that develops drugs to improve therapies for neurological conditions including multiple sclerosis and Parkinson's disease. The delivery order is for the delivery of Dalfampridine, an approved medication to help improve walking in adults with multiple sclerosis. This award does not have a set-aside designation.

Quick answers

Who was awarded contract VA77017J0923?

VA77017J0923 was awarded to Acorda Therapeutics, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on April 25, 2017.

How much is contract VA77017J0923 worth?

The government has obligated $485,835 on VA77017J0923.

Which agency awarded contract VA77017J0923?

Veterans Integrated Service Network 15 (Veterans Health Administration) awarded VA77017J0923, with funding from Veterans Integrated Service Network 12 (Veterans Health Administration).

Is contract VA77017J0923 an order under another contract?

Yes. VA77017J0923 is a delivery order under V797P5233B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA77017J0923 competed?

The extent of competition for VA77017J0923 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award